{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T11:53:59Z","timestamp":1772538839581,"version":"3.50.1"},"reference-count":74,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.cyto.2004.07.012","type":"journal-article","created":{"date-parts":[[2004,9,21]],"date-time":"2004-09-21T18:24:36Z","timestamp":1095791076000},"page":"167-173","source":"Crossref","is-referenced-by-count":74,"title":["New cytokine therapeutics for inflammatory bowel disease"],"prefix":"10.1016","volume":"28","author":[{"given":"P.C.F.","family":"Stokkers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.W.","family":"Hommes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2004.07.012_bib1","first-page":"1453","article-title":"Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein\/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function","volume":"279","author":"Badger","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.cyto.2004.07.012_bib2","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1172\/JCI118861","article-title":"Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses","volume":"98","author":"Berg","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2004.07.012_bib3","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0016-5085(99)70294-5","article-title":"The relationship between infliximab treatment and lymphoma in Crohn's disease","volume":"117","author":"Bickston","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2004.07.012_bib4","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1172\/JCI18545","article-title":"Connecting the dots from Toll-like receptors to innate immune cells and inflammatory bowel disease","volume":"111","author":"Boone","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2004.07.012_bib5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1126\/science.272.5258.60","article-title":"Lymphocyte homing and homeostasis","volume":"272","author":"Butcher","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.cyto.2004.07.012_bib6","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/ni735","article-title":"B cells and professional APCs recruit regulatory T cells via CCL4","volume":"2","author":"Bystry","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2004.07.012_bib7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1084\/jem.20021633","article-title":"Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide","volume":"197","author":"Caramalho","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2004.07.012_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0140-6736(93)91375-V","article-title":"Tumour-necrosis-factor antibody treatment in Crohn's disease","volume":"342","author":"Derkx","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2004.07.012_bib9","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0016-5085(99)70276-3","article-title":"Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial","volume":"117","author":"Ehrenpreis","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2004.07.012_bib10","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.4049\/jimmunol.163.3.1457","article-title":"NF-kappa B is a central regulator of the intestinal epithelial cell innate immune response induced by infection with enteroinvasive bacteria","volume":"163","author":"Elewaut","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2004.07.012_bib11","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1046\/j.1365-2036.1997.00251.x","article-title":"Treatment of ulcerative colitis with an engineered human anti-TNFalpha antibody CDP571","volume":"11","author":"Evans","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cyto.2004.07.012_bib12","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJM200006013422202","article-title":"A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease","volume":"342","author":"Feagan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cyto.2004.07.012_bib13","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1053\/gast.2000.20229","article-title":"Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease","volume":"119","author":"Fedorak","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2004.07.012_bib14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa020732","article-title":"Natalizumab for active Crohn's disease","volume":"348","author":"Ghosh","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cyto.2004.07.012_bib15","first-page":"1173","article-title":"Phase I safety and pharmacokinetic profile of an intercellular adhesion molecule-1 antisense oligodeoxynucleotide (ISIS 2302)","volume":"282","author":"Glover","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.cyto.2004.07.012_bib16","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1084\/jem.172.6.1625","article-title":"Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells","volume":"172","author":"Go","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2004.07.012_bib17","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1053\/gast.2001.26260","article-title":"A randomized placebo-controlled trial of a humanized monoclonal antibody to alpha4 integrin in active Crohn's disease","volume":"121","author":"Gordon","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2004.07.012_bib18","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1084\/jem.185.12.2101","article-title":"Altered immune responses in interleukin 10 transgenic mice","volume":"185","author":"Hagenbaugh","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2004.07.012_bib19","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJM199603283341307","article-title":"Inflammatory bowel disease","volume":"334","author":"Hanauer","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cyto.2004.07.012_bib20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1572-0241.2001.03671.x","article-title":"Management of Crohn's disease in adults","volume":"96","author":"Hanauer","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cyto.2004.07.012_bib21","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1053\/gast.1996.v111.pm8898653","article-title":"Rapid resolution of chronic colitis in the cotton-top tamarin with an antibody to a gut-homing integrin alpha 4 beta 7","volume":"111","author":"Hesterberg","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2004.07.012_bib22","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1053\/gast.2003.50153","article-title":"CARD15\/NOD2 functions as an antibacterial factor in human intestinal epithelial cells","volume":"124","author":"Hisamatsu","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2004.07.012_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1053\/gast.2002.30770","article-title":"Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease","volume":"122","author":"Hommes","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2004.07.012_bib24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/gut.52.1.144","article-title":"Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets","volume":"52","author":"Hommes","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.cyto.2004.07.012_bib25","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35079107","article-title":"Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease","volume":"411","author":"Hugot","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2004.07.012_bib26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s003840050175","article-title":"Etiology of the inflammatory bowel diseases","volume":"14","author":"Hugot","year":"1999","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.cyto.2004.07.012_bib27","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1084\/jem.194.6.847","article-title":"Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells","volume":"194","author":"Iellem","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2004.07.012_bib28","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1369-5274(02)00289-8","article-title":"Nods: a family of cytosolic proteins that regulate the host response to pathogens","volume":"5","author":"Inohara","year":"2002","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.cyto.2004.07.012_bib29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","article-title":"Innate immune recognition","volume":"20","author":"Janeway","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.cyto.2004.07.012_bib30","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1172\/JCI17085","article-title":"Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice","volume":"111","author":"Kobayashi","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2004.07.012_bib31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0092-8674(93)80068-P","article-title":"Interleukin-10-deficient mice develop chronic enterocolitis","volume":"75","author":"Kuhn","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2004.07.012_bib32","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.4049\/jimmunol.165.5.2783","article-title":"Proinflammatory effects of IL-10 during human endotoxemia","volume":"165","author":"Lauw","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2004.07.012_bib33","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJM200304173481615","article-title":"Natalizumab for active Crohn's disease","volume":"348","author":"Lew","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cyto.2004.07.012_bib34","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.4049\/jimmunol.145.12.4167","article-title":"IL-10, a novel growth cofactor for mature and immature T cells","volume":"145","author":"MacNeil","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2004.07.012_bib35","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.cyto.2004.07.012_bib36","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/gut.35.3.360","article-title":"Frequency of glucocorticoid resistance and dependency in Crohn's disease","volume":"35","author":"Munkholm","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.cyto.2004.07.012_bib37","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/gut.43.6.856","article-title":"Role of NF-kappaB in immune and inflammatory responses in the gut","volume":"43","author":"Neurath","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.cyto.2004.07.012_bib38","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/nm0996-998","article-title":"Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice","volume":"2","author":"Neurath","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.cyto.2004.07.012_bib39","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/35079114","article-title":"A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease","volume":"411","author":"Ogura","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2004.07.012_bib40","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1074\/jbc.M008072200","article-title":"Nod2, a Nod1\/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB","volume":"276","author":"Ogura","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cyto.2004.07.012_bib41","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1053\/gast.2000.18160","article-title":"Tumor necrosis factor: biology and therapeutic inhibitors","volume":"119","author":"Papadakis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2004.07.012_bib42","doi-asserted-by":"crossref","first-page":"903","DOI":"10.4049\/jimmunol.165.2.903","article-title":"Invasive Shigella flexneri activates NF-kappa B through a lipopolysaccharide-dependent innate intracellular response and leads to IL-8 expression in epithelial cells","volume":"165","author":"Philpott","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2004.07.012_bib43","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMra020831","article-title":"Inflammatory bowel disease","volume":"347","author":"Podolsky","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cyto.2004.07.012_bib44","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1053\/gast.2003.50157","article-title":"TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells","volume":"124","author":"Rosenstiel","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2004.07.012_bib45","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1365-2036.2003.01414.x","article-title":"Treatment of active Crohn's disease with onercept (recombinant human soluble p55 tumour necrosis factor receptor): results of a randomized, open-label, pilot study","volume":"17","author":"Rutgeerts","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cyto.2004.07.012_bib46","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/ni1102-1041","article-title":"Evasion of innate immunity by parasitic protozoa","volume":"3","author":"Sacks","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2004.07.012_bib47","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1053\/gast.2001.24042","article-title":"An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial","volume":"120","author":"Sandborn","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2004.07.012_bib48","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ibd.3780050209","article-title":"Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety","volume":"5","author":"Sandborn","year":"1999","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cyto.2004.07.012_bib49","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1053\/gast.2001.28674","article-title":"Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial","volume":"121","author":"Sandborn","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2004.07.012_bib50","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/gast.2002.33426","article-title":"Biologic therapy of inflammatory bowel disease","volume":"122","author":"Sandborn","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2004.07.012_bib51","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1053\/gast.2000.20196","article-title":"Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease","volume":"119","author":"Schreiber","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2004.07.012_bib52","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1053\/gast.2001.24015","article-title":"Absence of efficacy of subcutaneous antisense ICAM-1 treatment of chronic active Crohn's disease","volume":"120","author":"Schreiber","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2004.07.012_bib53","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0016-5085(99)70393-8","article-title":"The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls","volume":"117","author":"Schultsz","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2004.07.012_bib54","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1034\/j.1600-065X.2001.1820115.x","article-title":"Control of intestinal inflammation by regulatory T cells","volume":"182","author":"Singh","year":"2001","journal-title":"Immunol Rev"},{"key":"10.1016\/j.cyto.2004.07.012_bib55","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0092-8674(94)90337-9","article-title":"Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm","volume":"76","author":"Springer","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2004.07.012_bib56","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0140-6736(97)80083-9","article-title":"Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease","volume":"349","author":"Stack","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2004.07.012_bib57","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1126\/science.289.5483.1352","article-title":"Treatment of murine colitis by Lactococcus lactis secreting interleukin-10","volume":"289","author":"Steidler","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.cyto.2004.07.012_bib58","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/gast.2002.30294","article-title":"Mucosal flora in inflammatory bowel disease","volume":"122","author":"Swidsinski","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2004.07.012_bib59","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1074-7613(00)80005-9","article-title":"Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils","volume":"10","author":"Takeda","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2004.07.012_bib60","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/immu.200390017","article-title":"Increased expression of DC-SIGN+IL-12+IL-18+ and CD83+IL-12\u2212IL-18\u2212 dendritic cell populations in the colonic mucosa of patients with Crohn's disease","volume":"33","author":"te Velde","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cyto.2004.07.012_bib61","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/gut.50.2.206","article-title":"Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease","volume":"50","author":"ten Hove","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.cyto.2004.07.012_bib62","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.4049\/jimmunol.169.4.2204","article-title":"Role of IL-10 for induction of anemia during inflammation","volume":"169","author":"Tilg","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2004.07.012_bib63","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/gut.50.2.191","article-title":"Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma","volume":"50","author":"Tilg","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.cyto.2004.07.012_bib64","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/S0016-5085(03)00382-2","article-title":"Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease","volume":"124","author":"Van den Brande","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2004.07.012_bib65","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/gut.51.3.362","article-title":"Anti-tumour necrosis factor therapy in Crohn's disease: where are we now?","volume":"51","author":"van Deventer","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.cyto.2004.07.012_bib66","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1053\/bega.2002.0355","article-title":"Taming the mucosal immune response in Crohn's disease","volume":"16","author":"van Deventer","year":"2002","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.cyto.2004.07.012_bib67","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1053\/gast.1997.v113.pm9247454","article-title":"Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease","volume":"113","author":"van Deventer","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2004.07.012_bib68","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1053\/gast.2002.37066","article-title":"Generation of regulatory gut-homing human T lymphocytes using ex vivo interleukin 10 gene transfer","volume":"123","author":"van Montfrans","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2004.07.012_bib69","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1053\/gast.2002.37067","article-title":"Prevention of colitis by interleukin 10-transduced T lymphocytes in the SCID mice transfer model","volume":"123","author":"van Montfrans","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2004.07.012_bib70","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/S0016-5085(99)70277-5","article-title":"An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease","volume":"117","author":"Vasiliauskas","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2004.07.012_bib71","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.4049\/jimmunol.168.10.5342","article-title":"p38 mitogen-activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease","volume":"168","author":"Waetzig","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2004.07.012_bib72","first-page":"37","article-title":"Consequences of immunogenicity to the therapeutic monoclonal antibodies ReoPro and Remicade","volume":"112","author":"Wagner","year":"2003","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.cyto.2004.07.012_bib73","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0016-5085(98)70418-4","article-title":"A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease","volume":"114","author":"Yacyshyn","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2004.07.012_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/mgme.2001.3199","article-title":"Inflammatory bowel disease. I. Genetic epidemiology","volume":"74","author":"Yang","year":"2001","journal-title":"Mol Genet Metab"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466604002285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466604002285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T10:19:48Z","timestamp":1682763588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466604002285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":74,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S1043466604002285"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2004.07.012","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}